Immunome, Inc.
IMNMNASDAQHealthcare● Active
$18.61
+$0.03(+0.16%)
Market Cap$1.8B
P/E Ratio—
52W High$27.65
52W Low$7.96
Immunome, Inc.（IMNM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · IMNM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.94M | $9.04M | $14.02M | $0.00M | $0.00M |
| Cost of Revenue | $2.96M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $3.99M | $9.04M | $14.02M | $0.00M | $0.00M |
| Gross Margin %(computed) | 57.43% | 100.00% | 100.00% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $174.33M | $129.54M | $23.09M | $23.27M | $14.11M |
| G&A Expenses | $43.77M | $32.95M | $19.66M | $13.63M | $11.09M |
| Total Operating Expenses | $218.10M | $314.84M | $123.55M | $36.90M | $25.20M |
| Operating Income | ($214.11M) | ($305.80M) | ($109.53M) | ($36.90M) | ($25.20M) |
| Operating Margin %(computed) | — | — | -781.35% | — | — |
| Interest Income | $11.72M | $12.84M | $2.72M | $0.01M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.01M | $0.01M |
| Income Before Tax | ($212.39M) | ($292.96M) | ($106.81M) | ($36.90M) | ($24.71M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($212.39M) | ($292.96M) | ($106.81M) | ($36.90M) | ($24.71M) |
| Net Margin %(computed) | — | — | -761.92% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.43 | $-5.00 | $-5.38 | $-3.09 | $-2.14 |
| Wtd Avg Shares | 87.35M | 58.64M | 19.84M | 12.13M | 11.54M |
| EBITDA | ($211.16M) | ($151.35M) | ($28.00M) | ($36.27M) | ($24.45M) |
| EBITDA Margin %(computed) | — | — | -199.74% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Immunome, Inc.
关于Immunome, Inc.（IMNM）损益表
Immunome, Inc.（IMNM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，IMNM实现营收$0.01B，毛利润$0.00B（毛利率57.43%），净利润($0.21B)（净利率-3059.99%）。
常见问题
IMNM · 4 问Immunome, Inc.（IMNM）2025财年营收为$0.01B，同比down23.2%。
IMNM revenueIMNM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08